Received Jul 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Shingles in on his back and on his front; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 20-JUN-2025, the patient received Shingrix. In JUN-2025, less than a week after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles in on his back and on his front). The outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 24-JUN-2025 The patient received a dose of the Shingrix vaccine on Friday. It was not stated if it was the first or second dose. On Saturday (21-JUN-2025) or Sunday (22-JUN-2025), the patient began to break out in a full case of Shingles. The Shingles in on his back and on his front. The patient was taken to an urgent care facility and was prescribed an antiviral.